SSA
INDV icon

Schonfeld Strategic Advisors’s Indivior Pharmaceuticals INDV Stock Holding History

Schonfeld Strategic Advisors’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.37M Buy
+130,982
New +$4.75M 0.02% 621
2026
Q1 		– Sell
-34,835
Closed -$1.25M – 2434
2025
Q4 		$1.25M Sell
34,835
-1,297
-4% -$39.6K 0.01% 1035
2025
Q3 		$871K Buy
+36,132
New +$756K 0.01% 1442
2025
Q2 		– Sell
-178,825
Closed -$1.7M – 2262
2025
Q1 		$1.7M Buy
178,825
+43,164
+32% +$454K 0.01% 1031
2024
Q4 		$1.69M Buy
+135,661
New +$1.4M 0.01% 902
2024
Q3 		– Sell
-17,398
Closed -$280K – 2213
2024
Q2 		$280K Buy
+17,398
New +$314K ﹤0.01% 1717

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Schonfeld Strategic Advisors's INDV Position: Q2 2026 in Review

Schonfeld Strategic Advisors opened a new position in Indivior Pharmaceuticals (INDV) in Q2 2026: 130,982 shares worth $5.37M. The stake represents 0.02% of the portfolio and ranks #621 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in INDV as recently as Q4 2025.

Schonfeld Strategic Advisors first reported a position in INDV in Q2 2024 and has held it in 6 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Schonfeld Strategic Advisors held 130,982 shares of Indivior Pharmaceuticals worth $5.37M as of Q2 2026.
  • Indivior Pharmaceuticals was a new Schonfeld Strategic Advisors position in Q2 2026.
  • Indivior Pharmaceuticals made up 0.02% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #621 holding.
  • Schonfeld Strategic Advisors first reported a position in Indivior Pharmaceuticals in Q2 2024 and has held it in 6 quarters since.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.